J Epstein, H Preisler. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Bone Marrow/drug effectsBone Marrow/metabolismCells, CulturedColony-Forming Units AssayCytarabine/pharmacologyCytarabine/therapeutic useDNA, Neoplasm/biosynthesisDaunorubicin/therapeutic useDoxorubicin/therapeutic useDrug Therapy, CombinationHumansLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/metabolismThymidine/metabolism
Substances: See more » DNA, NeoplasmCytarabineDoxorubicinThymidineDaunorubicin
Year: 1981 PMID: 6946929 DOI: 10.1016/0014-2964(81)90264-4
Source DB: PubMed Journal: Eur J Cancer ISSN: 0014-2964 Impact factor: 9.162